Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

<p>Supplementary Table 1</p>

Enregistré dans:
Détails bibliographiques
Auteur principal: Lindsay M. Gurska (15056629) (author)
Autres auteurs: Rachel Okabe (15056632) (author), Alexandra Schurer (15056635) (author), Meng Maxine Tong (15056638) (author), Mark Soto (15056641) (author), Daniel Choi (15056644) (author), Kristina Ames (15056647) (author), Shira Glushakow-Smith (15056650) (author), Allison Montoya (15056653) (author), Ellen Tein (15056656) (author), Linde A. Miles (15056659) (author), Haiying Cheng (15056662) (author), Pamela Hankey-Giblin (15056665) (author), Ross L. Levine (15056668) (author), Swati Goel (15056671) (author), Balazs Halmos (15056674) (author), Kira Gritsman (15051360) (author)
Publié: 2025
Sujets:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Cell Signaling
Receptors
Hematological Cancers
Small Molecule Agents
Kinase inhibitors
Translational Research
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:<p>Supplementary Table 1</p>

Documents similaires